175 related articles for article (PubMed ID: 28792000)
1. [Lower extremity varicose veins in childhood and at a young age: Mechanism of development and specific features].
Studennikova VV; Severgina LO; Dzyundzya AN; Korovin IA
Arkh Patol; 2017; 79(4):56-60. PubMed ID: 28792000
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling.
Cario-Toumaniantz C; Boularan C; Schurgers LJ; Heymann MF; Le Cunff M; Léger J; Loirand G; Pacaud P
J Vasc Res; 2007; 44(6):444-59. PubMed ID: 17643059
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins.
Jacob T; Hingorani A; Ascher E
J Vasc Surg; 2005 Mar; 41(3):523-30. PubMed ID: 15838489
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β1 and inducible nitric oxide synthase signaling were involved in effects of prostaglandin E
Wang JC; Gu J; Li Y; Ma Q; Feng J; Lu S
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1535-1544. PubMed ID: 33482378
[TBL] [Abstract][Full Text] [Related]
5. [Ultrastructural characteristics of the mechanisms of varicose transformation of veins of different localization].
Studennikova VV; Severgina LO; Korovin IA; Rapoport LM; Krupinov GE; Novikov IA
Arkh Patol; 2020; 82(6):16-23. PubMed ID: 33274621
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of patients with lower limb varicose veins disease].
Chernykh KP; Kubachev KG; Semenov AY; Malyshev KV
Khirurgiia (Mosk); 2019; (5):88-93. PubMed ID: 31169826
[TBL] [Abstract][Full Text] [Related]
7. [Venous wall weackness pathogenesis in varicose vein disease].
Studennikova VV; Severgina LO; Sinyavin GV; Rapoport LM; Korovin IA
Khirurgiia (Mosk); 2019; (10):69-74. PubMed ID: 31626242
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.
Barallobre-Barreiro J; Oklu R; Lynch M; Fava M; Baig F; Yin X; Barwari T; Potier DN; Albadawi H; Jahangiri M; Porter KE; Watkins MT; Misra S; Stoughton J; Mayr M
Cardiovasc Res; 2016 Jun; 110(3):419-30. PubMed ID: 27068509
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 upregulation in the aging varicose vein.
Pascual G; Mendieta C; García-Honduvilla N; Corrales C; Bellón JM; Buján J
J Vasc Res; 2007; 44(3):192-201. PubMed ID: 17337905
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
Chen Y; Peng W; Raffetto JD; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
[TBL] [Abstract][Full Text] [Related]
11. Effects of high hemodynamics upon the morphology of the walls of the great saphenous vein and splenic vein.
Xu Y; Bian X; Chu H; Zhao J; Wang T; Tang J; Guo W; Zhang S
Int Angiol; 2014 Jun; 33(3):292-8. PubMed ID: 24936536
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of primary varicose veins.
Lim CS; Davies AH
Br J Surg; 2009 Nov; 96(11):1231-42. PubMed ID: 19847861
[TBL] [Abstract][Full Text] [Related]
13. In vitro differences between smooth muscle cells derived from varicose veins and normal veins.
Xiao Y; Huang Z; Yin H; Lin Y; Wang S
J Vasc Surg; 2009 Nov; 50(5):1149-54. PubMed ID: 19703751
[TBL] [Abstract][Full Text] [Related]
14. [Primary varicose veins--changes in the venous wall and elastic behavior].
Kirsch D; Wahl W; Böttger T; Junginger T
Chirurg; 2000 Mar; 71(3):300-5; discussion 305-6. PubMed ID: 10789047
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of acute venous thromboses in patients with varicose disease of lower extremity veins].
Khanevich MD; Stoĭko IuM; Shchelokova AL; Zubritskiĭ VF; Grigor'ev KS
Vestn Khir Im I I Grek; 2005; 164(5):15-8. PubMed ID: 16768330
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities.
Shadrina AS; Smetanina MA; Sevost'yanova KS; Shevela AI; Seliverstov EI; Zakharova EA; Voronina EN; Ilyukhin EA; Zolotukhin IA; Kirienko AI; Filipenko ML
Bull Exp Biol Med; 2017 Sep; 163(5):650-654. PubMed ID: 28944430
[TBL] [Abstract][Full Text] [Related]
17. Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3.
Sansilvestri-Morel P; Rupin A; Jullien ND; Lembrez N; Mestries-Dubois P; Fabiani JN; Verbeuren TJ
J Vasc Res; 2005; 42(5):388-98. PubMed ID: 16088212
[TBL] [Abstract][Full Text] [Related]
18. Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins.
Sansilvestri-Morel P; Nonotte I; Fournet-Bourguignon MP; Rupin A; Fabiani JN; Verbeuren TJ; Vanhoutte PM
J Vasc Res; 1998; 35(2):115-23. PubMed ID: 9588875
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation.
Raffetto JD; Ross RL; Khalil RA
J Vasc Surg; 2007 Feb; 45(2):373-80. PubMed ID: 17264019
[TBL] [Abstract][Full Text] [Related]
20. Role of Rho kinase signalling in healthy and varicose human saphenous veins.
Cario-Toumaniantz C; Evellin S; Maury S; Baron O; Pacaud P; Loirand G
Br J Pharmacol; 2002 Sep; 137(2):205-12. PubMed ID: 12208777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
